Dr. Yen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1560 E Chevy Chase Dr
Suite 140
Glendale, CA 91206Phone+1 818-409-8000
Education & Training
- Kaiser Permanente Southern California (Los Angeles)Residency, Family Medicine, 2000 - 2003
- Albert Einstein College of MedicineClass of 2000
Certifications & Licensure
- CA State Medical License 2001 - 2019
Clinical Trials
- A Study to Evaluate Safety and Tolerability After Single Oral Dosing of AZD1656 in Japanese Healthy Volunteers Start of enrollment: 2008 Aug 01
- AZD7325 Single Ascending Dose Study in Healthy Male Japanese Subjects Start of enrollment: 2008 Oct 01
- AZD6765 Single and Multiple Ascending Dose Study in Healthy Male and Female Japanese and Caucasian Subjects Start of enrollment: 2008 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 8 citationsCharacterization of the disposition of fostamatinib in Japanese subjects including pharmacokinetic assessment in dry blood spots: results from two phase I clinical stu...Paul D. Martin, S. Y. Amy Cheung, Mark Yen, David Han, Michael Gillen
European Journal of Clinical Pharmacology. 2016-01-01 - 13 citationsPharmacokinetics, Safety, and Tolerability of a Single 500-mg or 1000-mg Intravenous Dose of Dalbavancin in Healthy Japanese Subjects.Patrick Scoble, Robert C. Owens, Sailaja Puttagunta, Mark Yen, Michael W. Dunne
Clinical Drug Investigation. 2015-10-12
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: